Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome
Introduction
Hepatocellular carcinoma (HCC) is a common malignancy worldwide1 and has been difficult to treat successfully. Although surgical resection offers patients with HCC a chance for cure, the post-resectional tumour recurrence rate is high with a cumulative 5-year tumour recurrence rates ranging from 40 to 70%.2., 3.
In HCC patients, many studies have described the prognostic factors related to post-hepatectomy recurrence or survival, but little has been documented on the characteristics and long-term prognosis of patients with recurrent HCC. In prolonging survival after resection of HCC, effective treatment of patients with recurrence is critical. Several investigators have demonstrated that aggressive management of patients with intrahepatic and/or extrahepatic recurrences of HCC, including repeat hepatic resection4., 5. and resection of isolated extrahepatic recurrence,6 offers patients a chance of long-term survival.
Our study aimed to determine the prognosis of patients with recurrent HCC after a hepatic resection and identify the factors related to survival after tumour recurrence.
Section snippets
Patients and methods
Between July 1991 and December 2000, 623 patients with HCC underwent curative hepatic resection at the Department of Surgery, Taipei Veterans General Hospital, Taiwan. A curative resection was defined as an operation in which all the tumours were macroscopically resected during surgery. Thirty-two patients had a microscopic positive surgical margin on subsequent histologic examination. Details of pre-operative investigations, operative techniques, and perioperative management have been reported
Prognosis after tumour recurrence
Of the 286 patients, the disease-free survival periods after hepatic resection were mean 15.4±17.5 months; median 9.0 months; and range 1–97.4 months. The overall survival periods after hepatic resection were mean 39.7±30.6 months; median 31.0 months; and range 1.7–137.4 months. Survival times after tumour recurrence were mean 24.3±22.4 months; median 17.8 months; and range 10 days–135 months. The overall 1-, 3-, 5-, and 10-year survival rates from the time of recurrence were 61.5, 33.4, 18.2,
Discussion
This study demonstrates that prognosis of patients with recurrent HCC varied widely with 60.5% patients died within 2 years after tumour recurrence while 8.0% of patients survived more than 5 years. Independent adverse factors of survival after HCC recurrence included multiple initial tumours, period until recurrence <1 year, presence of extrahepatic recurrence, recurrent tumour size >2 cm, multiple recurrent tumours, and non-resectional treatment for recurrent tumour(s). These findings
References (24)
- et al.
Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy
J Am Coll Surg
(2002) - et al.
Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s)
Eur J Surg Oncol
(1996) - et al.
Clinical significance of microscopic tumour venous invasion in patients with resectable hepatocellular carcinoma
Surgery
(2000) - et al.
Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan
Gastroenterology
(1996) - et al.
Rising incidence of hepatocellular carcinoma in the United States
N Engl J Med
(1999) - et al.
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
Ann Surg
(2000) - et al.
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma
Ann Surg
(2000) - et al.
Clinical management of recurrent hepatocellular carcinoma
Ann Surg
(1995) - et al.
Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma
Ann Surg
(1998) - et al.
Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter
Br J Surg
(1998)
Operative approaches to hepatocellular carcinoma in the cirrhotic patient
Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma
Arch Surg
Cited by (102)
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group
2022, HPBCitation Excerpt :Despite significant advances in diagnostic techniques and early effective treatments, rHCC is common and represents a major global health issue. After liver resection 5-year recurrence rate is about 50–70%, reaching up to 80% in patients treated with RFA.1,2,7 According to Tabrizian et al. recurrence also cause a 24% reduction in 5-year survival.1
Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy
2022, Annals of HepatologyImpact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation
2022, Journal of Gastrointestinal SurgeryIL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-γ
2020, Biochemical and Biophysical Research Communications